Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
GlobeNewswire, Inc.
Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine platform designed to reduce risk and...
Odysight.ai Receives Purchase Order from Elbit Systems on Behalf of the Israeli Ministry of Defense for Deployment of Its Vision-Based Prognostics and Health Management System
GlobeNewswire, Inc.
The purchase order, valued at approximately $0.3 million (NIS 1.0 million), expands Odysight.ai’s operational portfolio and may lead to wide deployment across the Israeli Defense Forces upon successful completion Ramat Gan, Israel, July 08, 2026...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
GlobeNewswire, Inc.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
BrainsWay Featured in USA Today America250 Segment Highlighting Future of Mental Health Treatment and Neuromodulation
EIN Presswire
Advances in neuromodulation are challenging conventional approaches and expanding non‑drug treatment options for depression and other mental health conditions BURLINGTON, MA, UNITED STATES, July 7, 2026 /EINPresswire.com/ -- BrainsWay Ltd....
Pain Monitoring Data to be Available in Hospital EHRs through Philips Capsule
EIN Presswire
The integration enables streaming of the patient’s NOL-Nociception Level Index® data to EHRs, supporting personalized analgesia in surgery and critical care.
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
GlobeNewswire, Inc.
The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April Heightened awareness generating interest from leading health systems across the U.S. as Company plans to...
BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement
GlobeNewswire, Inc.
NETANYA, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), announced today following its April 16, 2026 announcement that its wholly-owned subsidiary Zorronet has commenced supply and...
PRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data
GlobeNewswire, Inc.
TEL AVIV, Israel, July 08, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced that its DeepSolar business unit has completed an initial validation phase for DeepSolar Predict™, the Company’s next...
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
GlobeNewswire, Inc.
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials Dr. Ricordi to support advancement of NewcelX's Type 1 Diabetes program and...
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
GlobeNewswire, Inc.
NETANYA, Israel, July 08, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "Company"), a company focused on acquiring and further developing technologies that identify, analyze, protect against and support faster responses...
BrainsWay Featured in USA Today America250 Segment Highlighting Future of Mental Health Treatment and Neuromodulation
EIN Presswire
Advances in neuromodulation are challenging conventional approaches and expanding non‑drug treatment options for depression and other mental health conditions BURLINGTON, MA, UNITED STATES, July 2, 2026 /EINPresswire.com/ -- BrainsWay Ltd....
Reporting live from Gaza and the West Bank, senior sector officials – alongside global medical and human rights leaders
EIN Presswire
UN Commission of Inquiry: Israel’s operations led to the destruction of conditions necessary for child survival in Gaza and West Bank GAZA, GAZA, PALESTINE, July 2, 2026 /EINPresswire.com/ -- Reporting live from Gaza and the West Bank, senior...
HUB Cyber Security Expands Into Women’s Health With Zero-Cash Acquisition of Evofem Notes, Advances Balance Sheet Turnaround
GlobeNewswire, Inc.
TEL AVIV, Israel, July 01, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), today announced that it has acquired certain senior subordinated convertible notes and purchase rights of Evofem Biosciences, Inc....
ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)
GlobeNewswire, Inc.
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days of Patent Term Adjustment Notice of allowance also received in a corresponding Canadian patent...
UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
GlobeNewswire, Inc.
FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient enrollment expected to begin in Q4 2026 UGN-501 is a differentiated investigational next-generation...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
GlobeNewswire, Inc.
NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
GlobeNewswire, Inc.
HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into a Letter of Agreement (LOA) with Sanmina Corporation, a...
Chair Walberg Delivers Remarks at Markup to Combat Antisemitism, Protect Student Freedoms, Support Workers, and Increase Health Care Transparency
U.S. House Committee on Education and the Workforce
Today, Education and Workforce Committee Chairman Tim Walberg (R-MI) delivered the following statement, as prepared for delivery, at a markup of 11 bills: "Today we’ll mark up 11 bills that address antisemitism in educational institutions, protect...
@EdWorkforceCmte Passes 11 Bills on Antisemitism, Student Freedoms, Workforce Policy, and Health Care
U.S. House Committee on Education and the Workforce
The Education and Workforce Committee passed 11 bills today to combat antisemitism in educational institutions, protect students' freedom of association, help licensed professionals work across state lines, strengthen accessibility and...
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
GlobeNewswire, Inc.
HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical...
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.